Dietary Plant Sterols Supplementation Increases In Vivo Nitrite and Nitrate Production in Healthy Adults: A Randomized, Controlled Study

Xing Lin Ho, Wai Mun Loke, Xing Lin Ho, Wai Mun Loke

Abstract

A randomized, double-blinded, placebo-controlled and crossover study was conducted to simultaneously measure the effects, 3 h after consumption and after 4-wk daily exposure to plant sterols-enriched food product, on in vivo nitrite and nitrate production in healthy adults. Eighteen healthy participants (67% female, 35.3 [mean] ± 9.5 [SD] years, mean body mass index 22.8 kg/m2 ) received 2 soy milk (20 g) treatments daily: placebo and one containing 2.0 g free plant sterols equivalent of their palmityl esters (β-sitosterol, 55%; campesterol, 29%; and stigmasterol, 23%). Nitrite and nitrate concentrations were measured in the blood plasma and urine, using stable isotope-labeled gas chromatography-mass spectrometry. L-arginine and asymmetric dimethylarginine concentrations in blood serum were measured using commercially available enzyme immunoassays. Nitrite and nitrate concentrations in blood plasma (nitrite 5.83 ± 0.50 vs. 4.52 ± 0.27; nitrate 15.78 ± 0.96 vs. 13.43 ± 0.81 μmol/L) and urine (nitrite 1.12 ± 0.22 vs. 0.92 ± 0.36, nitrate 12.23 ± 1.15 vs. 9.71 ± 2.04 μmol/L) were significantly elevated after 4-wk plant sterols supplementation Placebo and 3-h treatments did not affect the blood plasma and urinary concentrations of nitrite and nitrate. Circulating levels of L-arginine and asymmetric dimethylarginine were unchanged in the placebo and treatment arms. Total plant sterols, β-Sitosterol, campesterol, and stigmasterol concentrations were significantly elevated after 4-wk treatments compared to the placebo and 3-h treatments. Blood plasma nitrite and nitrate concentrations correlated significantly with the plasma total and specific plant sterol concentrations. Our results suggest that dietary plant sterols, in the combination used, can upregulate nitrite, and nitrate production in vivo.

Keywords: L-arginine; nitrate; nitric oxide; nitrite; plant sterols.

© 2017 Institute of Food Technologists®.

Figures

Figure 1
Figure 1
(A) Nitrite and (B) nitrate concentrations in blood plasma of 18 healthy adults before (baseline), 3 h after intervention (3 h) and after 4‐wk daily exposure (4 wk) of the placebo and plant sterols esters (2 g free plant sterols equivalent)‐enriched soy milk. *,P < 0.05 compared with placebo soy milk after baseline adjustment (mixed model analysis with Tukey's test).
Figure 2
Figure 2
(A) Nitrite and (B) nitrate concentrations in the urine of 18 healthy adults before (baseline), 3 h after intervention (3 h) and after 4‐wk daily exposure (4 wk) of the placebo and plant sterols esters (2 g free plant sterols equivalent)‐enriched soy milk. *,P < 0.05 compared placebo soy milk after baseline adjustment (mixed model analysis with Tukey's test).
Figure 3
Figure 3
(A) Arginine and (B) asymmetric dimethylarginine concentrations in blood plasma of 18 healthy adults before (baseline), 3 h after intervention (3 h) and after 4‐wk daily exposure (4 wk) of the placebo and plant sterols esters (2 g free plant sterols equivalent)‐enriched soy milk. *,P < 0.05 compared placebo soy milk after baseline adjustment (mixed model analysis with Tukey's test).
Figure 4
Figure 4
Changes (%) in (A) nitrite and (B) nitrate formation by phorbol 12‐myristat 13‐acetate‐stimulated human blood neutrophils treated with β‐sitosterol (●), campesterol (■), stigmasterol (▲) and plant sterols mixture (50% β‐sitosterol, 30% campesterol, 20% stigmasterol w/w, ▼; 0 to 50 μmol/L) compared to the untreated phorbol 12‐myristat 13‐acetate‐stimulated human blood neutrophils. *,P < 0.05 compared with others using ANOVA of AUC with Bonferroni post hoc adjustment.

References

    1. AbuMweis SS, Barake R, Jones PJH. 2008. Plant sterols/stanols as cholesterol lowering agents: a meta‐analysis of randomized controlled trials. Food Nutr Res 52(1):1811–24.
    1. Ahmida HSM, Bertucci P, Franzò L, Massoud R, Cortese C, Lala A, Federici G. 2006. Simultaneous determination of plasmatic phytosterols and cholesterol precursors using gas chromatography–mass spectrometry (GC–MS) with selective ion monitoring (SIM). J Chromatogr B 842(1):43–7.
    1. Ardigo D, Stüehlinger M, Franzini L, Valtuena S, Piatti P, Pachinger O, Reaven G, Zavaroni I. 2007. ADMA is independently related to flow‐mediated vasodilation in subjects at low cardiovascular risk. Eur J Clin Invest 37(4):263–9.
    1. Awad AB, Smith AJ, Fink CS. 2001. Plant sterols regulate rat vascular smooth muscle cell growth and prostacyclin release in culture. Prostagl Leukotr Essent Fatty Acids 64(6):323–30.
    1. Chan Y‐M, Demonty I, Pelled D, Jones PJ. 2007. Olive oil containing olive oil fatty acid esters of plant sterols and dietary diacylglycerol reduces low‐density lipoprotein cholesterol and decreases the tendency for peroxidation in hypercholesterolaemic subjects. Br J Nutr 98(3):563–70.
    1. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. 1996. Oral L‐arginine improves endothelium‐dependent dilation in hypercholesterolemic young adults. J Clin Invest 97(8):1989–94.
    1. De Jong A, Plat J, Bast A, Godschalk RWL, Basu S, Mensink RP. 2007. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low‐grade inflammation in patients on current statin treatment. Eur J Clin Nutr 62(2):263–73.
    1. De Jongh S, Vissers M, Rol P, Bakker H, Kastelein J, Stroes E. 2003. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J Inherit Metabol Dis 26(4):343–52.
    1. Demonty I, Ras RT, van der Knaap HCM, Duchateau GSMJE, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. 2008. Continuous dose‐response relationship of the LDL‐cholesterol–lowering effect of phytosterol intake. J Nutr 139(2):1–10.
    1. Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch TI, Poole DC. 2013. Impact of dietary nitrate supplementation via beetroot juice on exercising muscle vascular control in rats. J Physiol 591(2):547–57.
    1. Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch TI, Poole DC. 2014. Dose dependent effects of nitrate supplementation on cardiovascular control and microvascular oxygenation dynamics in healthy rats. Nitric Oxide 39:51–8.
    1. Gladwin MT, Raat NJ, Shiva S, Dezfulian C, Hogg N, Kim‐Shapiro DB, Patel RP. 2006. Nitrite as a vascular endocrine nitric oxide reservoir that contributes to hypoxic signaling, cytoprotection, and vasodilation. Am J Physiol ‐ Heart Circ Physiol 291(5):H2026–H35.
    1. Hadaegh F, Asgari S, Bozorgmanesh M, Jeddi S, Azizi F, Ghasemi A. 2016. Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric Oxide 54:60–6.
    1. Hallikainen M, Lyyra‐Laitinen T, Laitinen T, Ågren JJ, Pihlajamäki J, Rauramaa R, Miettinen TA, Gylling H. 2006. Endothelial function in hypercholesterolemic subjects: effects of plant stanol and sterol esters. Atherosclerosis 188(2):425–32.
    1. Harrison DG. 1997. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100(9):2153.
    1. Ho X, Tsen SY, Ng MY, Lee WN, Low A, Loke WM. 2016. Aged garlic , not raw garlic precursor, supplement protects against lipid peroxidation in hypercholesterolemic individuals. J Med Food 19:931–7.
    1. Hu FB, Willett WC. 2002. Optimal diets for prevention of coronary heart disease. J Am Med Assoc 288(20):2569–78.
    1. Kielstein A, Tsikas D, Galloway GP, Mendelson JE. 2007. Asymmetric dimethylarginine (ADMA)—a modulator of nociception in opiate tolerance and addiction? Nitric Oxide 17(2):55–9.
    1. Kleinbongard P, Dejam A, Lauer T, Jax T, Kerber S, Gharini P, Balzer J, Zotz RB, Scharf RE, Willers R, Schechter AN, Feelisch M, Kelm M. 2006. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Rad Biol Med 40(2):295–302.
    1. Kleinbongard P, Dejam A, Lauer T, Rassaf T, Schindler A, Picker O, Scheeren T, Gödecke A, Schrader J, Schulz R, Heusch G, Schaub GA, Bryan NS, Feelisch M, Kelm M. 2003. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Rad Biol Med 35(7):790–6.
    1. Lau VW, Journoud M, Jones PJ. 2005. Plant sterols are efficacious in lowering plasma LDL and non‐HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons. Am J Clin Nutr 81(6):1351–8.
    1. Leone A, Moncada S, Vallance P, Calver A, Collier J. 1992. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339(8793):572–5.
    1. Li H, Förstermann U. 2000. Nitric oxide in the pathogenesis of vascular disease. J Pathol 190(3):244–54.
    1. Ling WH, Jones PJH. 1995. Dietary phytosterols: a review of metabolism, benefits, and side effects. Life Sci 57(3):195–206.
    1. Loke WM, Lam KM‐J, Chong WL, Chew SE, Quek AM, Lim EC, Seet RC. 2012. Products of 5‐lipoxygenase and myeloperoxidase activities are increased in young male cigarette smokers. Free Rad Res 46(10):1230–7.
    1. Maxwell AJ, Cooke JP. 1998. Cardiovascular effects of L‐arginine. Curr Opin Nephol Hypertens 7(1):63–70.
    1. Nagase S, Takemura K, Ueda A, Hirayama A, Aoyagi K, Kondoh M, Koyama A. 1997. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D‐or L‐arginine. Biochem Biophys Res Comm 233(1):150–3.
    1. Ostlund RE, McGill JB, Zeng C‐M, Covey DF, Stearns J, Stenson WF, Spilburg CA. 2002. Gastrointestinal absorption and plasma kinetics of soy Δ5‐phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab 282(4):E911–E6.
    1. Päivä H, Kähönen M, Lehtimäki T, Alfthan G, Viikari J, Laaksonen R, Hutri‐Kähönen N, Laitinen T, Taittonen L, Raitakari OT. 2010. Levels of asymmetrical dimethylarginine are predictive of brachial artery flow‐mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 212(2):512–5.
    1. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiß C, Strauer B‐E, Feelisch M, Kelm M. 2002. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 109(9):1241–8.
    1. Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S. 1995. The L‐Arginine: Nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Comm 209(2):590–6.
    1. Thorne S, Mullen MJ, Clarkson P, Donald AE, Deanfield JE. 1998. Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L‐arginine. J Am Coll Cardiol 32(1):110–6.
    1. Tsikas D. 2000. Simultaneous derivatization and quantification of the nitric oxide metabolites nitrite and nitrate in biological fluids by gas chromatography/mass spectrometry. Anal Chem 72(17):4064–72.
    1. Verma S, Anderson TJ. 2002. Fundamentals of endothelial function for the clinical cardiologist. Circulation 105(5):546–9.
    1. Vita JA, Keaney JF. 2002. Endothelial function a barometer for cardiovascular risk? Circulation 106(6):640–2.
    1. Willeit P, Freitag DF, Laukkanen JA, Chowdhury S, Gobin R, Mayr M, Di Angelantonio E, Chowdhury R. 2015. Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta‐analysis of 22 prospective studies. J Am Heart Assoc 4(6):e001833.
    1. Zamani P, Rawat D, Shiva‐Kumar P, Geraci S, Bhuva R, Konda P, Doulias P‐T, Ischiropoulos H, Townsend RR, Margulies KB, Cappola TP, Poole DC, Chirinos JA. 2015. Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation 131(4):371–80.
    1. Zamani P, Tan VX, Soto‐Calderon H, Beraun M, Brandimarto J, Trieu L, Varakantam S, Doulias P‐T, Townsend RR, Chittams J, Margulies KB, Cappola TP, Poole DC, Ischiropoulos H, Chirinos JA. 2016. Pharmacokinetics and pharmacodynamics of inorganic nitrate in heart failure with preserved ejection fraction. Circulation 134:A15751.

Source: PubMed

3
Subskrybuj